Cargando…
Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
The toxicity of amyloid β and tau, the two hallmark proteins in Alzheimer’s disease (AD), has been extensively studied individually. Recently new data suggest their possible interactions and synergistic effects in the disease. In this study, we investigate the ability of antibodies against the β sec...
Autores principales: | Rabinovich-Nikitin, Inna, Rakover, Idan S., Becker, Maria, Solomon, Beka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468631/ https://www.ncbi.nlm.nih.gov/pubmed/23071606 http://dx.doi.org/10.1371/journal.pone.0046650 |
Ejemplares similares
-
Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS
por: Rabinovich-Toidman, Polina, et al.
Publicado: (2015) -
Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer’s disease treatment
por: Gavriel, Yuval, et al.
Publicado: (2021) -
Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2016) -
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease
por: Kang, Seong Su, et al.
Publicado: (2020) -
Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
por: Wu, Zhourui, et al.
Publicado: (2020)